Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 14 |
GO:0110165 | cellular anatomical entity | 1 | 14 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A0A3S7X4J5
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 14 |
GO:0006643 | membrane lipid metabolic process | 4 | 14 |
GO:0006665 | sphingolipid metabolic process | 4 | 14 |
GO:0006672 | ceramide metabolic process | 4 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0008152 | metabolic process | 1 | 14 |
GO:0008610 | lipid biosynthetic process | 4 | 14 |
GO:0009058 | biosynthetic process | 2 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 14 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 14 |
GO:0043603 | amide metabolic process | 3 | 14 |
GO:0043604 | amide biosynthetic process | 4 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 14 |
GO:0044249 | cellular biosynthetic process | 3 | 14 |
GO:0044255 | cellular lipid metabolic process | 3 | 14 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 14 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 14 |
GO:0046513 | ceramide biosynthetic process | 5 | 14 |
GO:0071704 | organic substance metabolic process | 2 | 14 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 14 |
GO:1901576 | organic substance biosynthetic process | 3 | 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0016410 | N-acyltransferase activity | 5 | 14 |
GO:0016740 | transferase activity | 2 | 14 |
GO:0016746 | acyltransferase activity | 3 | 14 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 14 |
GO:0050291 | sphingosine N-acyltransferase activity | 6 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 246 | 252 | PF00089 | 0.561 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.353 |
CLV_NRD_NRD_1 | 281 | 283 | PF00675 | 0.297 |
CLV_NRD_NRD_1 | 284 | 286 | PF00675 | 0.290 |
CLV_NRD_NRD_1 | 298 | 300 | PF00675 | 0.264 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.736 |
CLV_NRD_NRD_1 | 453 | 455 | PF00675 | 0.583 |
CLV_NRD_NRD_1 | 458 | 460 | PF00675 | 0.580 |
CLV_PCSK_FUR_1 | 282 | 286 | PF00082 | 0.221 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.267 |
CLV_PCSK_KEX2_1 | 281 | 283 | PF00082 | 0.305 |
CLV_PCSK_KEX2_1 | 284 | 286 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.736 |
CLV_PCSK_KEX2_1 | 453 | 455 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 458 | 460 | PF00082 | 0.582 |
CLV_PCSK_PC1ET2_1 | 221 | 223 | PF00082 | 0.284 |
CLV_PCSK_PC1ET2_1 | 458 | 460 | PF00082 | 0.537 |
CLV_PCSK_PC7_1 | 454 | 460 | PF00082 | 0.539 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.340 |
CLV_PCSK_SKI1_1 | 300 | 304 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 408 | 412 | PF00082 | 0.539 |
DOC_ANK_TNKS_1 | 10 | 17 | PF00023 | 0.440 |
DOC_CYCLIN_yCln2_LP_2 | 185 | 191 | PF00134 | 0.361 |
DOC_MAPK_gen_1 | 136 | 144 | PF00069 | 0.539 |
DOC_MAPK_MEF2A_6 | 143 | 152 | PF00069 | 0.508 |
DOC_PP2B_LxvP_1 | 183 | 186 | PF13499 | 0.354 |
DOC_PP2B_LxvP_1 | 25 | 28 | PF13499 | 0.491 |
DOC_PP4_FxxP_1 | 171 | 174 | PF00568 | 0.275 |
DOC_SPAK_OSR1_1 | 104 | 108 | PF12202 | 0.636 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.462 |
DOC_USP7_MATH_1 | 431 | 435 | PF00917 | 0.772 |
DOC_USP7_MATH_1 | 436 | 440 | PF00917 | 0.739 |
DOC_USP7_UBL2_3 | 139 | 143 | PF12436 | 0.611 |
DOC_USP7_UBL2_3 | 296 | 300 | PF12436 | 0.573 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.679 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.455 |
DOC_WW_Pin1_4 | 340 | 345 | PF00397 | 0.354 |
LIG_14-3-3_CanoR_1 | 128 | 134 | PF00244 | 0.691 |
LIG_14-3-3_CanoR_1 | 299 | 303 | PF00244 | 0.549 |
LIG_14-3-3_CanoR_1 | 305 | 313 | PF00244 | 0.530 |
LIG_14-3-3_CanoR_1 | 35 | 39 | PF00244 | 0.508 |
LIG_14-3-3_CanoR_1 | 4 | 12 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 42 | 46 | PF00244 | 0.442 |
LIG_Actin_WH2_2 | 373 | 391 | PF00022 | 0.578 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.484 |
LIG_BRCT_BRCA1_1 | 156 | 160 | PF00533 | 0.330 |
LIG_Clathr_ClatBox_1 | 213 | 217 | PF01394 | 0.451 |
LIG_EH1_1 | 230 | 238 | PF00400 | 0.374 |
LIG_FHA_1 | 232 | 238 | PF00498 | 0.315 |
LIG_FHA_1 | 7 | 13 | PF00498 | 0.480 |
LIG_GBD_Chelix_1 | 356 | 364 | PF00786 | 0.376 |
LIG_LIR_Gen_1 | 100 | 109 | PF02991 | 0.607 |
LIG_LIR_Gen_1 | 17 | 27 | PF02991 | 0.426 |
LIG_LIR_Gen_1 | 44 | 55 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 100 | 105 | PF02991 | 0.629 |
LIG_LIR_Nem_3 | 157 | 163 | PF02991 | 0.348 |
LIG_LIR_Nem_3 | 167 | 173 | PF02991 | 0.244 |
LIG_LIR_Nem_3 | 17 | 22 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 223 | 228 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 247 | 253 | PF02991 | 0.274 |
LIG_LIR_Nem_3 | 321 | 327 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 52 | 57 | PF02991 | 0.350 |
LIG_LYPXL_S_1 | 81 | 85 | PF13949 | 0.391 |
LIG_LYPXL_yS_3 | 82 | 85 | PF13949 | 0.391 |
LIG_NRBOX | 355 | 361 | PF00104 | 0.318 |
LIG_Pex14_1 | 149 | 153 | PF04695 | 0.343 |
LIG_Pex14_1 | 354 | 358 | PF04695 | 0.421 |
LIG_Pex14_2 | 320 | 324 | PF04695 | 0.318 |
LIG_REV1ctd_RIR_1 | 322 | 332 | PF16727 | 0.346 |
LIG_SH2_CRK | 108 | 112 | PF00017 | 0.590 |
LIG_SH2_CRK | 19 | 23 | PF00017 | 0.431 |
LIG_SH2_CRK | 330 | 334 | PF00017 | 0.468 |
LIG_SH2_NCK_1 | 189 | 193 | PF00017 | 0.361 |
LIG_SH2_STAP1 | 19 | 23 | PF00017 | 0.454 |
LIG_SH2_STAT3 | 162 | 165 | PF00017 | 0.330 |
LIG_SH2_STAT3 | 273 | 276 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 273 | 276 | PF00017 | 0.338 |
LIG_SH2_STAT5 | 330 | 333 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.580 |
LIG_SH3_3 | 185 | 191 | PF00018 | 0.268 |
LIG_SH3_3 | 77 | 83 | PF00018 | 0.391 |
LIG_SUMO_SIM_anti_2 | 234 | 242 | PF11976 | 0.345 |
LIG_SUMO_SIM_anti_2 | 74 | 79 | PF11976 | 0.322 |
LIG_SUMO_SIM_par_1 | 234 | 242 | PF11976 | 0.345 |
LIG_SUMO_SIM_par_1 | 261 | 268 | PF11976 | 0.354 |
LIG_SUMO_SIM_par_1 | 373 | 379 | PF11976 | 0.411 |
LIG_TRAF2_1 | 191 | 194 | PF00917 | 0.352 |
LIG_TRAF2_1 | 418 | 421 | PF00917 | 0.778 |
LIG_TYR_ITIM | 80 | 85 | PF00017 | 0.443 |
LIG_UBA3_1 | 213 | 221 | PF00899 | 0.468 |
MOD_CDK_SPK_2 | 131 | 136 | PF00069 | 0.679 |
MOD_CDK_SPK_2 | 340 | 345 | PF00069 | 0.318 |
MOD_CDK_SPxxK_3 | 131 | 138 | PF00069 | 0.615 |
MOD_CDK_SPxxK_3 | 340 | 347 | PF00069 | 0.354 |
MOD_CK1_1 | 309 | 315 | PF00069 | 0.488 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.473 |
MOD_CK1_1 | 439 | 445 | PF00069 | 0.779 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.477 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.435 |
MOD_CK2_1 | 390 | 396 | PF00069 | 0.677 |
MOD_CK2_1 | 406 | 412 | PF00069 | 0.698 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.515 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.557 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.638 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.561 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.639 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.451 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.424 |
MOD_GSK3_1 | 336 | 343 | PF00069 | 0.380 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.476 |
MOD_GSK3_1 | 396 | 403 | PF00069 | 0.710 |
MOD_GSK3_1 | 406 | 413 | PF00069 | 0.701 |
MOD_GSK3_1 | 436 | 443 | PF00069 | 0.773 |
MOD_GSK3_1 | 444 | 451 | PF00069 | 0.780 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.431 |
MOD_LATS_1 | 406 | 412 | PF00433 | 0.716 |
MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.667 |
MOD_N-GLC_1 | 448 | 453 | PF02516 | 0.565 |
MOD_N-GLC_1 | 45 | 50 | PF02516 | 0.530 |
MOD_N-GLC_2 | 314 | 316 | PF02516 | 0.421 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.417 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.417 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.330 |
MOD_NEK2_1 | 378 | 383 | PF00069 | 0.594 |
MOD_NEK2_1 | 410 | 415 | PF00069 | 0.733 |
MOD_NEK2_1 | 440 | 445 | PF00069 | 0.774 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.250 |
MOD_NEK2_2 | 336 | 341 | PF00069 | 0.329 |
MOD_PIKK_1 | 448 | 454 | PF00454 | 0.738 |
MOD_PKA_1 | 284 | 290 | PF00069 | 0.421 |
MOD_PKA_1 | 453 | 459 | PF00069 | 0.796 |
MOD_PKA_2 | 284 | 290 | PF00069 | 0.551 |
MOD_PKA_2 | 292 | 298 | PF00069 | 0.529 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.497 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.519 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.455 |
MOD_PKA_2 | 431 | 437 | PF00069 | 0.709 |
MOD_PKA_2 | 453 | 459 | PF00069 | 0.796 |
MOD_PKB_1 | 282 | 290 | PF00069 | 0.491 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.361 |
MOD_Plk_1 | 309 | 315 | PF00069 | 0.466 |
MOD_Plk_1 | 73 | 79 | PF00069 | 0.285 |
MOD_Plk_2-3 | 390 | 396 | PF00069 | 0.625 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.374 |
MOD_Plk_4 | 209 | 215 | PF00069 | 0.360 |
MOD_Plk_4 | 232 | 238 | PF00069 | 0.401 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.513 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.300 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.672 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.458 |
MOD_ProDKin_1 | 340 | 346 | PF00069 | 0.354 |
MOD_SUMO_rev_2 | 420 | 425 | PF00179 | 0.786 |
TRG_ENDOCYTIC_2 | 108 | 111 | PF00928 | 0.537 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.405 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.318 |
TRG_ENDOCYTIC_2 | 370 | 373 | PF00928 | 0.403 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.446 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.430 |
TRG_ER_diArg_1 | 135 | 138 | PF00400 | 0.667 |
TRG_NLS_MonoExtN_4 | 135 | 142 | PF00514 | 0.575 |
TRG_Pf-PMV_PEXEL_1 | 408 | 412 | PF00026 | 0.513 |
TRG_Pf-PMV_PEXEL_1 | 95 | 100 | PF00026 | 0.413 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2N8 | Leptomonas seymouri | 64% | 100% |
A0A0S4JEY3 | Bodo saltans | 32% | 100% |
A0A0S4JIF9 | Bodo saltans | 34% | 100% |
A0A1X0NPU5 | Trypanosomatidae | 46% | 100% |
A0A1X0NPY1 | Trypanosomatidae | 47% | 100% |
A0A422MNN3 | Trypanosoma rangeli | 46% | 100% |
A4HJG0 | Leishmania braziliensis | 70% | 100% |
A4I6V5 | Leishmania infantum | 99% | 100% |
C9ZMC0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
C9ZWR6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9B1X8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q684 | Leishmania major | 95% | 100% |